Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Contemporary Management of HIV: Evolving Issues in First-line Combination Therapy

Listen to expert insights from Joseph J. Eron, Jr., MD, and Daniel R. Kuritzkes, MD, on evolving considerations for first-line HIV therapy, including 2-drug regimens, weight gain, and pregnancy safety.
Released: December 29, 2020

In this episode, Joseph J. Eron, Jr., MD; and Daniel R. Kuritzkes, MD; discuss evolving issues in first-line antiretroviral therapy, including 2-drug therapy, weight gain, and safety during conception and pregnancy.

Presenters:

Joseph J. Eron, Jr., MD
Professor of Medicine and Epidemiology
University of North Carolina 
School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women’s Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
ViiV Healthcare

Related Content

CCO commentary by Dr. Gregory Huhn on ART and weight gain including perspectives and new data on potential pathophysiology and implications

Gregory Huhn, MD, MPHTM Released: June 17, 2021

Clinical Care Options’ (CCO) podcast with Dr. David Wohl on current guidelines and clinical trial data informing selection of ART in a newly diagnosed patient with HIV, HBV, and obesity

David A. Wohl, MD Released: June 15, 2021

Slides from CCO: Switching ART in HIV: 3-drug therapy, oral 2-drug options, long-acting injectable 2-drug regimens, single tablet regimens (STRs)

Daniel R. Kuritzkes, MD Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: June 7, 2021

Latesha Elopre and CCO: starting HIV pre-exposure prophylaxis (PrEP). DISCOVER study, CDC guidance, racial/ethnic disparities, overcoming barriers

Latesha Elopre, MD, MSPH Released: June 7, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue